Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon J Draper

Showing results (81-90 of 165) with videos related to

Pageof 17
Sort By:
BMC Biotechnology|July 26, 2011
The generation and evaluation of recombinant human IgA specific for Plasmodium falciparum merozoite surface protein 1-19 (PfMSP1 19)Jianguo Shi, Richard S McIntosh, Jaime Adame-Gallegos, et al.
Frontiers in Microbiology|February 1, 2019
Antibody Responses to Antigenic Targets of Recent Exposure Are Associated With Low-Density Parasitemia in Controlled Human <i>Plasmodium falciparum</i> InfectionsLotus L van den Hoogen, Jona Walk, Tate Oulton, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 27, 2026
Targeting vaccine fusion proteins to APCs increases immunogenicity of adenoviral and mRNA-LNP vaccinesMarlene Fyrstenberg Laursen, Francis Combes, Arnar Gudjonsson, et al.
Immunology|December 6, 2013
Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infectionSean C Elias, Prateek Choudhary, Simone C de Cassan, et al.
Plos Pathogens|October 9, 2023
Cellular iron governs the host response to malariaSarah K Wideman, Joe N Frost, Felix C Richter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2010
Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccinesSimon J Draper, Sumi Biswas, Alexandra J Spencer, et al.
Cell Reports. Medicine|August 2, 2021
Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodiesAlexandra C Willcox, Alex S Huber, Ababacar Diouf, et al.
Frontiers in Immunology|July 29, 2015
Preclinical Assessment of Viral Vectored and Protein Vaccines Targeting the Duffy-Binding Protein Region II of Plasmodium VivaxSimone C de Cassan, A Rushdi Shakri, David Llewellyn, et al.
Frontiers in Cellular and Infection Microbiology|July 5, 2022
Expanding the Malaria Antibody Toolkit: Development and Characterisation of <i>Plasmodium falciparum</i> RH5, CyRPA, and CSP Recombinant Human Monoclonal AntibodiesAdéla Nacer, Gaily Kivi, Raini Pert, et al.
Scientific Reports|September 17, 2015
Standardization of the antibody-dependent respiratory burst assay with human neutrophils and Plasmodium falciparum malariaDavid Llewellyn, Kazutoyo Miura, Michael P Fay, et al.
Pageof 17

Showing results (81-90 of 165) with videos related to

Sort By:
Pageof 17
BMC Biotechnology|July 26, 2011
The generation and evaluation of recombinant human IgA specific for Plasmodium falciparum merozoite surface protein 1-19 (PfMSP1 19)Jianguo Shi, Richard S McIntosh, Jaime Adame-Gallegos, et al.
Frontiers in Microbiology|February 1, 2019
Antibody Responses to Antigenic Targets of Recent Exposure Are Associated With Low-Density Parasitemia in Controlled Human <i>Plasmodium falciparum</i> InfectionsLotus L van den Hoogen, Jona Walk, Tate Oulton, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 27, 2026
Targeting vaccine fusion proteins to APCs increases immunogenicity of adenoviral and mRNA-LNP vaccinesMarlene Fyrstenberg Laursen, Francis Combes, Arnar Gudjonsson, et al.
Immunology|December 6, 2013
Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infectionSean C Elias, Prateek Choudhary, Simone C de Cassan, et al.
Plos Pathogens|October 9, 2023
Cellular iron governs the host response to malariaSarah K Wideman, Joe N Frost, Felix C Richter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2010
Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccinesSimon J Draper, Sumi Biswas, Alexandra J Spencer, et al.
Cell Reports. Medicine|August 2, 2021
Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodiesAlexandra C Willcox, Alex S Huber, Ababacar Diouf, et al.
Frontiers in Immunology|July 29, 2015
Preclinical Assessment of Viral Vectored and Protein Vaccines Targeting the Duffy-Binding Protein Region II of Plasmodium VivaxSimone C de Cassan, A Rushdi Shakri, David Llewellyn, et al.
Frontiers in Cellular and Infection Microbiology|July 5, 2022
Expanding the Malaria Antibody Toolkit: Development and Characterisation of <i>Plasmodium falciparum</i> RH5, CyRPA, and CSP Recombinant Human Monoclonal AntibodiesAdéla Nacer, Gaily Kivi, Raini Pert, et al.
Scientific Reports|September 17, 2015
Standardization of the antibody-dependent respiratory burst assay with human neutrophils and Plasmodium falciparum malariaDavid Llewellyn, Kazutoyo Miura, Michael P Fay, et al.
Pageof 17